Pilar Carvallo

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Suppression of breast cancer metastatic behavior by microRNAs targeting EMT transcription factors. A relevant participation of miR-196a-5p and miR-22-3p in ZEB1 expression.

Suppression of breast cancer metastatic behavior by microRNAs targeting EMT transcription factors. A relevant participation of miR-196a-5p and miR-22-3p in ZEB1 expression.

Journal: Breast cancer research and treatment

Published: July 08, 2024

BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients.

BRCA1 and BRCA2 screening of nine Chilean founder mutations through allelic-discrimination and real-time PCR in breast/ovarian cancer patients.

Journal: Molecular biology reports

Published: January 05, 2022

Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.

Haplotype analysis of the internationally distributed BRCA1 c.3331_3334delCAAG founder mutation reveals a common ancestral origin in Iberia.

Journal: Breast cancer research : BCR

Published: April 01, 2020

EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features.

EGFR pathway subgroups in Chilean colorectal cancer patients, detected by mutational and expression profiles, associated to different clinicopathological features.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: September 23, 2017

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

Journal: Oncotarget

Published: April 28, 2017

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.

Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.

Journal: Gastroenterology

Published: April 05, 2016

miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.

miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.

Journal: Cancer biomarkers : section A of Disease markers

Published: February 03, 2016

Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.

Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.

Journal: BMC cancer

Published: July 15, 2015

BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.

BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.

Journal: Breast cancer research and treatment

Published: March 10, 2015

Large deletions and splicing-site mutations in the STK11 gene in Peutz-Jeghers Chilean families.

Large deletions and splicing-site mutations in the STK11 gene in Peutz-Jeghers Chilean families.

Journal: Clinical genetics

Published: March 22, 2012

Homozygous germline mutation in MUTYH gene in familial adenomatous polyposis

Homozygous germline mutation in MUTYH gene in familial adenomatous polyposis

Journal: Revista medica de Chile

Published: November 07, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026